Refundability promises to dominate the federal government's long-overdue review of its highly touted R&D tax incentive program. Announced October 5, consultations on possible changes to the scientific research and experimental development (SR&ED) program will likely generate consensus that extending refundability to all R&D-performing companies is the minimum the business community is willing to accept.